Recruiting studies: Opioid Agonist Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Mobile Platform for Optimizing Wellness and Engagement in Recovery
NA · 1 location(s) · University of Michigan · NCT07178990 HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Phase 4 · 6 location(s) · Cara Spence · NCT07160075 Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
Phase 4 · 2 location(s) · Pouya Azar · NCT07439549 Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Phase 2 · 1 location(s) · BC Centre on Substance Use · NCT05985850 Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Phase 2 · 1 location(s) · Parnassia Addiction Research Centre · NCT05529927 GLP-1R Agonist Treatment for Opioid Use Disorder
Phase 2 · 4 location(s) · Milton S. Hershey Medical Center · NCT06548490 Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist
NA · 1 location(s) · University of Notre Dame · NCT07342504 Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Phase 3 · 9 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT03646058 Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
NA · 1 location(s) · Boston Medical Center · NCT06732596 Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Phase 2/Phase 3 · 6 location(s) · University of British Columbia · NCT04893525

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.